TCL Archive Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’ December 11, 1992
TCL Archive As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal February 3, 1995
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs. April 30, 2004
